News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Aeris Therapeutics, Inc. Receives US Patent 8,198,365 with Broad Claims to Methods of Non-Surgical Lung Volume Reduction


6/13/2012 10:56:16 AM

WOBURN, Mass.--(BUSINESS WIRE)--Aeris Therapeutics, LLC announced that the U.S. Patent and Trademark Office has issued a patent covering the use of cross-linked polymers administered into the lung to reduce lung volume for the treatment of emphysema. This newly issued patent, entitled "Lung Volume Reduction Therapy Using Crosslinked Non-Natural Polymers," covers novel technology that enables lung volume reduction therapy without high risk surgery.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES